Thyrotropin-releasing hormone administration does not affect seizure threshold during electroconvulsive therapy

Journal of ECT

Volumn 19, Issue 3, 2003, Pages 136-138

  Zervas, Iannis M ^a   Papakostas, Yiannis G ^a   Theodoropoulou, Maria A ^a   Dimitrakopoulos, Christos ^a   Vaidakis, Nikos ^a   Daras, Michael ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE

Author keywords

Electroconvulsive therapy; Seizure duration; Seizure threshold; Stimulus titration procedure; Thyrotropin releasing hormone (TRH)

Indexed keywords

LORAZEPAM; PROTIRELIN; THYROTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; ELECTRICITY; ELECTROCONVULSIVE THERAPY; FEMALE; GRAND MAL SEIZURE; HUMAN; SEIZURE; SEIZURE THRESHOLD; TITRIMETRY;

ADULT; AGED; AGED, 80 AND OVER; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MIDDLE AGED; SEIZURES; THYROTROPIN-RELEASING HORMONE;

EID: 0042887102     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124509-200309000-00004     Document Type: Article

References (15)

1. Sackeim H, Decina P, Prohovnik I, et al. Seizure threshold in Electroconvulsive therapy: effects on sex, age, electrode placement and number of treatments. Arch Gen Psychiatry. 1987;44:355-360.
2. Lerer B. The neurobiology of ECT: The road taken (editorial). J ECT. 1998;14:149-152.
3. Sattin A. The role of TRH and related peptides in the mechanism of action of ECT. J ECT. 1999;15:76-92.
4. Papakostas YG, Markianos M, Pehlivanidis A, et al. Blunted TSH response to TRH and seizure duration in ECT. Acta Psychiatr Scand. 1999;99:68-72.
5. Sackeim H. The anticonvulsant hypothesis of the mechanism of action of ECT: current status. J ECT. 1999;15:76-92.
6. Sackeim H, Prudic J, Kiersky JE, et al. Effects os stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med. 1993;328:839-846.
7. Devanand DP, Lisanby SH, Nobler MS, et al. The relative efficacy of altering pulse frequency or trian duration when determining seizure threshold. J ECT. 1998;14:227-235.
8. Coffey CE, Lucke J, Weiner RD. Krystal Ad and Aque M. Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. Biol Psychiatry. 1995;37:713-720.
9. Griffiths EC. TRH: endocrine and central effects. Psychoendocrinology. 1985;10:225-235.
10. Friedman TC, Yanovsky JA, Jayasvasti V, et al. Pyroglutyl peptidase II ("thyroliberinase") activity in human serum: influence of weight and thyroid status. J Clin Endocrinol Metab. 1995;80:1086-1089.
11. Khan A, Mirolo MH, Claypool K, et al. Effects of low-dose TRH on cognitive deficits in the ECT post-ictal state. Am J Psychiatry. 1994;151:1694-1696.
12. Zervas IM, Pehlivanidis AA, Papakostas YG, et al. Effects of TRH administration on orientation time and recall after ECT. J ECT. 1998;14:236-240.
13. Bolwig TM, Hertz MM, Paulson OB, et al. The permeability of the blood-brain barrier dusring electrically induced seizures in man. Eur J Clin Invest. 1977;7:87-93.
14. Callahan AM, Frye MA, Marangell LB, et al. Comparative antidepressant effects of parenteral and intrathecal thyrotropin releasing hormone: confounding effects of tolerance and implications for thrapeutics. Biol Psychiatry. 1997;41:264-272.
15. Marangell LB, Callahan AM, George MS, et al. Effects of intrathecal thyrotropin-releasing hormone (TRH) in refractory depressed patients. Arch Gen Psychiatry. 1997;54:214-222.